|
|||||||||
|
|||||||||
|
|||||||||
Through Probiotic Supplementation
17. Lukaczer D. The probiotic solution for colitis. Nutrition Science News, Newsletter 2000;:494-501.
18. Friend BA, Shahani KM. Nutritional and therapeutic aspects of lactobacilli. J Appl Nutr 1984;36:126-53.
19. Leavitt J, Barrett JC, Crawford BD, Tso POP. Butyric acid suppression on the in vitro neoplastic state of Syrian hamster cells. Nature 1978;271:262.
20. Mallett AK, Bearne CA, Rowland IR. The influence of incubation pH on the activity of rat and human gut flora enzymes. J Appl Bacteriol 1989;66:433-37.
21. Saloff-Coste CJ. Overview of diarrhea. WWW: http://www.danonevitapole.com/nutri_views/newsletter/index_newsletter.html (accessed 21 Nov 1999).
22. Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol 2000;95(suppl):S2-S4.
23. Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol 2000;95(Suppl):S11-13.
24. Frost F, Craun G, Calderon R. Increasing hospitalization and death possibly due to Clostridium difficle diarrheal disease. Emerg Infect Dis 1997;24:324-333.
25. Fekety R, McFarland LV, Surawicz CM, et al. Recurrent Clostridium difficle diarrhea: Characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997;24:324-333.
26. Klebanoff SJ, Coombs RW. Viricidal Effect of Lactobacillus Acidophilus on Human Immunodeficiency Virus Type 1: Possible Role in Heterosexual Transmission. J Exp Med 1991;174:289-292.
27. Marteau P, Rambaud J-C. Potential of using lactic acid bacteria for therapy and immu nomodulation in man. FEMS Microbiol Rev 1993;12:207.
28. McCracken BJ, Gaskins HR. Probiotics and the immune system. In: Tannock GW, ed. Probiotics: A Critical Review. Norfolk, England: Horizon Scientific Press; 1999:85-111. Book review.
29. Perdigon G, Alvarez S. Probiotics and the immune state. In: Fuller R, ed. Probiotics. The Scientific Basis. London: Chapman and Hall; 1992:145.
30. Tomioka H, Saito H. Lactic acid bacteria in the support of immunocompromised hosts. In: Wood BJB, ed. The Lactic Acid Bacteria. Volume 1. The Lactic Acid Bacteria in Health and Disease. London: Elsevier Applied Science. 1992;:263.
31. Taranto MP, Medici M, Perdigon G, Ruiz Holgado AP, Valdez GF. Evidence for hypercholesterolemic effect of Lactobacillus reuteri in hypercholesterolemic mice. J Dairy Sci 1998;81(9):2336-40.
32. Sanders ME. Probiotics. Food Technol 1999;53(11):67-77.
33. Se Simone C, Ciardi A, Grassi A, Lambert Gardini S, Tzantzoglou S, Trinchieri V, Moretti S, Jirillo E. Effect of Bifidobacterium bifidum and Lactobacillus Acidophilus on gut mucosa and peripheral blood B lymphocytes. Immunopharmacol Immunotoxicol 1992;14:331-340.
34. Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular disease. Eur J Clin Nutr 2000;54(4):288-9.
35. Goldin BR. Health benefits of probiotics. Br J Nutr 1998;80(S2):203-07. WWW: http://www.oxiline.com.br/download/probio-health.pdf (downloaded 26 Nov 2001).
36. Reid G. MINIREVIEW
The scientific basis for probiotic strains of Lactobacillus. App Environ
Microbiol 1999;65(9):3763-766. WWW: http://www.oxiline.com.br/download/probio-scienti-base.pdf
(downloaded 26 Nov 2001).
